Yearly and 5-year outcome of patients on home parenteral nutrition for intestinal failure included in the follow-up. Baseline inclusion, 1 January 2004
| Non-candidates for ITx No. 389 (A 296, C 93) | Candidates for ITx No. 156 (A 99, C 57) | |||||||
| Lost to follow-up | Weaned off HPN | Deceased on HPN | Transplanted | Lost to follow-up | Weaned off HPN | Deceased on HPN | Transplanted | |
| 31 December 2004 | 34 (A 15, C 19) 1A restarted | 8 (A 8) | 2 (A 1, C 1) | 5 (A 5) | 5 (A 2, C 3) | |||
| 31 December 2005 | 29 (A 17, C 12) | 5 (A 4, C 1) | 6 (A 3, C 3) | 5 (A 2, C 3) | ||||
| 31 December 2006 | 10 (A 10) | 6 (A 2, C 4) | 5 (A 5) | 1 (A 1) | 1 (A 1) Restarted | 7 (A 7) | 5 (A 2, C 3) | |
| 31 December 2007 | 9 (A 8, P 1) | 17 (A 10, C 7) | 12 (A 11, C 1) | 6 (A 6) | 3 (A 1, C 2) | 5 (A 4, C 1) | 2 (A 2) | |
| 31 December 2008 | 7 (A 2, C 5) | 8 (A 6, C 2) | 1 (C 1) | 2 (A 2) | 4 (A 2, C 2) | |||
| 5-year outcome | 19 (4.9%) (A 18, P 1) | 92 (23.6%) (A 45, C 47) | 38 (9.8%) (A 34, C 4) | 1 (0.3%) (C 1) | 7 (4.5%) (A 7) | 5 (3.2%) (A 2, C 3) | 25 (16.0%) (A 21, C 4) | 21 (13.5%) (A 10, C 11) |
5-year outcome: p<0.001 between non-candidates and candidates; 11 non-candidates were referred/listed for ITx; indications were: HPN/IF-associated liver failure, 2; CVC-related venous thrombosis, 4; CVC-related sepsis, 1; severe dehydration, 4. One underwent transplantation (CVC-related vein thrombosis) and 1 was weaned off HPN. All were alive at the end of the study.
A, adults; HPN, home parenteral nutrition; ITx, intestinal transplantation; C, children (≤18 years).